Biotech & Pharma

First test of gene therapy for rare form of autism is underway

25 sec read10 views0 listens

A biotech startup has begun testing a gene therapy for a rare, severe form of autism, aiming to deliver a crucial gene for neural connection development; this marks a pioneering approach in treating genetic autism, potentially offering hope for similar conditions; content creators should highlight the innovative medical advancements and potential impacts on rare disease treatments.

Read the full article at Endpoints News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

Startups & VC4 hours ago24 sec read

The new startup playbook: From product velocity to cognitive positioning

Southeast Asian startups are shifting their focus from traditional metrics like product velocity and customer acquisition towards cognitive positioning, as AI commoditizes technological products. This change is crucial because in saturated markets, c...

Ali Nemati

Startups & VC4 hours ago24 sec read

Malaysia's OSKVI and Affin Hwang move into venture debt with Pothos Fund I

Malaysia's OSK Ventures International and Affin Hwang Investment Bank have launched Pothos Fund I, a venture debt fund targeting high-growth Southeast Asian companies. This move signals a growing trend in alternative financing, offering startups a wa...

Ali Nemati

Startups & VC19 hours ago23 sec read

Craft's Ilya Levtov Never Learned To Code. He Built A Software Company Anyway.

Ilya Levtov, a non-technical founder of Craft, a supply chain software company, highlights the challenges and advantages of building a tech startup without coding skills. Despite lacking technical expertise, Levtov successfully raised $42 million and...

Ali Nemati